Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1541
Participant characteristics (non-weighted).
Published 2024“…Differences were noted between the models of only males and only females. Decreased walking endurance is associated with a decreased likelihood of walking in the community—a factor that can be addressed by rehabilitation professionals and in community based programs.…”
-
1542
-
1543
-
1544
-
1545
-
1546
Fig 2A–2C and 2G–2L Data.
Published 2023“…We observed a marked decrease in nocturnal locomotion of <i>Opn5</i><sup><i>cre</i></sup><i>; Gnas</i><sup><i>fl/fl</i></sup> mice at both 28°C and 22°C, but no overall differences in energy expenditure, respiratory exchange, or food and water consumption. …”
-
1547
HRMECs treated with 3-Deazaneplanocin A (DZNep) chemical inhibitor demonstrated increased miR-200b and decreased VEGF expression.
Published 2015“…[NG = 5mM D-glucose, HG = 25mM D-glucose, NG+DMSO = 5mM D-glucose + 0.05% DMSO, HG+DMSO = 25mM D-glucose + 0.05% DMSO, NG+DZNEP = 5mM D-glucose + 5μM DZNep, HG+DZNEP = 25mM + 5μM DZNep; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to β-actin for VEGF and U6 for miR-200b, expressed as a fold change of NG].…”
-
1548
-
1549
-
1550
-
1551
-
1552
-
1553
-
1554
-
1555
-
1556
-
1557
-
1558
-
1559
Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease
Published 2015“…Here we tested whether lithium treatment would decrease levels of GFAP in a mouse model of Alexander disease. …”
-
1560